Anna Rose Childress, Ph.d.
Clinical trials sponsored by Anna Rose Childress, Ph.d., explained in plain language.
-
Magic mushroom drug tested as potential breakthrough for opioid crisis
Disease control Recruiting nowThis study is testing whether a single dose of psilocybin, the active compound in 'magic mushrooms,' can help people with opioid addiction. Researchers will give 36 people in treatment either a 25mg dose or a very low 1mg dose to see if the higher dose improves their ability to t…
Phase: PHASE2 • Sponsor: Anna Rose Childress, Ph.D. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Magic mushrooms target addiction brain circuits in new trial
Disease control Recruiting nowThis study is testing whether psilocybin, the active compound in 'magic mushrooms,' can change brain activity related to drug cravings and self-control in people with opioid addiction. Researchers will give 24 participants either a low or high dose and use brain scans to see how …
Phase: PHASE2 • Sponsor: Anna Rose Childress, Ph.D. • Aim: Disease control
Last updated Mar 16, 2026 15:38 UTC